PMAIP1 and prostate carcinoma: The consistent association of high Noxa expression with poor prognosis in prostate cancer contrasts with its pro-apoptotic function and warrants further investigation into how elevated Noxa might contribute to aggressive disease, perhaps by indicating a high level of apoptotic priming that the tumor has overcome through other compensatory anti-apoptotic mechanisms.